Announcements Trials
Browse Landscape

Phase

Phase 1 7Phase 3 2Phase 1/2 2Phase 2 1

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 149Gastrointestinal 31Gynecologic 26Breast 26Genitourinary 25Head & Neck 23Dermatologic 15Endocrine 13Sarcoma 9Other solid neoplasm 6NET 5Lymphoid 3CNS 3Plasma cell 2Other hematologic neoplasm 2Myeloid 1Classical hematology 1

Conditions

Multiple Myeloma 444Neoplasms, Plasma Cell 77Recurrence 62Lymphoma 52Lymphoma, Non-Hodgkin 48Leukemia 43Hodgkin Disease 43Leukemia, Myeloid, Acute 42Myelodysplastic Syndromes 37Leukemia, Lymphocytic, Chronic, B-Cell 35Precursor Cell Lymphoblastic Leukemia-Lymphoma 34Lymphoma, Mantle-Cell 29Lymphoma, Large B-Cell, Diffuse 29Lymphoma, Follicular 27Hematologic Neoplasms 24Burkitt Lymphoma 24Immunoglobulin Light-chain Amyloidosis 22Myeloproliferative Disorders 21Lymphoma, B-Cell, Marginal Zone 21Waldenstrom Macroglobulinemia 18Lymphoma, Large-Cell, Immunoblastic 18Neoplasms 17Lymphoma, T-Cell, Cutaneous 16Lymphoma, Large-Cell, Anaplastic 14Leukemia, Myelomonocytic, Chronic 14Leukemia, Myelogenous, Chronic, BCR-ABL Positive 14Sezary Syndrome 13Mycosis Fungoides 13Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 12Leukemia, Myeloid, Accelerated Phase 12

Interventions

carfilzomib 1Rituximab 1Gemcitabine 1Dexamethasone 1Capecitabine 1Bendamustine Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Small Cell Lung Carcinoma × Plasma cell × Clear all
NCT03997968 2024-12-24

A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors

Cyteir Therapeutics, Inc.

Phase 1/2 Completed
169 enrolled
BreastGastrointestinalGynecologicHead & NeckLymphoidPlasma cellSarcomaThoracic

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Head and Neck Neoplasms, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Sarcoma, Lymphoma, Mantle-Cell, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT00531284 2017-08-15

Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma

Amgen

Phase 1/2 Completed
184 enrolled 36 charts
GenitourinaryGynecologicLymphoidPlasma cellThoracic

Carcinoma, Non-Small-Cell Lung, Kidney Neoplasms, Lymphoma, Multiple Myeloma, Ovarian Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡